Medical technology manufacturer ulrich medical has reported significant growth for 2022 at around €136 million. The company increased its sales by 12 per cent compared to the previous year.
“Thanks to the consistent implementation of our sustainable business development strategy and our high quality products, which users value, as well as the high level of commitment shown by all our employees, we have succeeded in continuing on our growth path,” said chief executive officer Klaus Kiesel.
The overall group closed last year with a profit in the double-digit million range and it again succeeded in significantly topping the average sales growth of 3.3 per cent in the medical technology sector as determined in the BVMed autumn survey.
Managing partner Christoph Ulrich added: “We are proud of the result and look positively towards the new business year. With the unrestricted supply capability of our products, we are and will remain a reliable partner for our customers in 2023.”
Picture: Kiesel and Ulrich in the company’s production area.
Published on page 12 of the March 2023 issue of RAD Magazine.